Company Name: |
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
|
Tel: |
18818260767 |
Email: |
sales@chemegen.com |
Products Intro: |
Product Name:NSC16168 CAS:6837-93-0 Purity:98% Package:10 mg;50 mg;100 mg;500 mg;1 g;5 g;10 g
|
|
| 4-amino-5-(tosyloxy)naphthalene-2,7-disulfonic acid Basic information |
Product Name: | 4-amino-5-(tosyloxy)naphthalene-2,7-disulfonic acid | Synonyms: | 4-amino-5-(tosyloxy)naphthalene-2,7-disulfonic acid;1-Amino-8-(4-methylphenylsulfonyloxy)naphthalene-3,6-disulfonic acid;4-Amino-5-[[(4-methylphenyl)sulfonyl]oxy]-2,7-naphthalenedisulfonic acid;8-Amino-1-(4-methylphenylsulfonyloxy)-3,6-naphthalenedisulfonic acid;4-amino-5-(4-methylphenyl)sulfonyloxynaphthalene-2,7-disulfonic acid;2,7-Naphthalenedisulfonic acid, 4-amino-5-[[(4-methylphenyl)sulfonyl]oxy]-;NSC16168,NSC-16168 | CAS: | 6837-93-0 | MF: | C17H15NO9S3 | MW: | 473.5 | EINECS: | | Product Categories: | | Mol File: | 6837-93-0.mol | |
| 4-amino-5-(tosyloxy)naphthalene-2,7-disulfonic acid Chemical Properties |
density | 1.5197 (rough estimate) | refractive index | 1.7000 (estimate) | storage temp. | Store at -20°C | solubility | DMSO: 31.25 mg/mL (66.00 mM) | form | Solid | pka | -1.16±0.40(Predicted) | color | Off-white to gray |
| 4-amino-5-(tosyloxy)naphthalene-2,7-disulfonic acid Usage And Synthesis |
Biological Activity | NSC16168 is a specific ERCC1-XPF inhibitor with IC50 value of 0.42 μM. It inhibits DNA repair and enhances the efficacy of CDDP in cancer. | in vitro | NSC16168 (0-50 μM) potentiates cisplatin efficacy in cancer cells. Cell Viability Assay. < td class="col1"> Cell Line: H460 cells. | Concentration: | 0-50 μM. | Incubation Time: | 2 h. | Result: | Potentiated cisplatin efficacy in cancer cells. | table> in vivo | NSC16168 (20 mg/kg, ip, twice daily) exhibits significant anti-tumor activity and potentiates cisplatin antitumor activity in H460 lung cancer xenografts. < /b> Animal Model: | 2.5×10 6 H460 cells were injected sc in the right flank of each mouse. | tr> Dosage: | 20 mg/kg. | Administration: | IP, twice daily for 10 days. | Result: | The tumor growth was minimally affected by compound and the mice displayed no signs of distress or toxic side effects. The combination treatment with 16168 and cisplatin inhibited H460 tumor growth, which was maintained for the duration of the compound injections. | | target | IC50: 0.42 μM (ERCC1-XPF). |
| 4-amino-5-(tosyloxy)naphthalene-2,7-disulfonic acid Preparation Products And Raw materials |
|
Tag:4-amino-5-(tosyloxy)naphthalene-2,7-disulfonic acid(6837-93-0)
Related Product Information
|
|
According to the laws, regulations and policies related to "patent products", the sale of this product is prohibited!
ChemicalBook prompt
The patent owner or licensee of the product has not released any relevant information for the time being.
|